Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial

Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial

Abstract Aims Venoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly being used in circulatory failure. The main indications are cardiogenic shock, post‐cardiotomy cardiac failure, and refractory cardiac arrest. However, VA‐ECMO weaning is particularly challenging, and weaning fa...

Full description

Bibliographic Details
Main Authors: Omar Ellouze, Agnès Soudry Faure, Mohamed Radhouani, Osama Abou‐Arab, Emmanuel Besnier, Mouhamed Moussa, Amélie Cransac, Elea Ksiazek, Marc‐Olivier Fischer, Paul Michel Mertes, Belaid Bouhemad, Pierre Grégoire Guinot
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Levosimendan
Heart failure
ECMO
Weaning
Mortality
Online Access:https://doi.org/10.1002/ehf2.13427

Internet

https://doi.org/10.1002/ehf2.13427

Similar Items